Epogen (epoetin alfa)

EPOGEN (epoetin alfa) – an erythropoiesis-stimulating agent (ESA)commonly used to treat anemia due to various conditions. Epogen stimulate erythropoiesis through the same mechanism as endogenous (naturally occurring) erythropoietin. FDA approved uses: Epogen is indicated for the treatment of anemia due to: Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis. Zidovudine in […]

Neulasta (pegfilgrastim)

NEULASTA (pegfilgrastim) – a leukocyte growth factor that is commonly used to decrease the incidence of infection in patients receiving myelosuppressive anti-cancer drugs. FDA approved uses: Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence […]